POSTER SESSION
Poster Instructions: Guidelines

Your poster can be presented
during Lunches & Poster Viewing Session

It must be 70 centimetres wide (across) and 100 centimetres high (vertical).

You may display your poster from 20th June 2007 at 14h00. Your presence near it is kindly requested during lunches and coffee breaks for discussion.

Please PRINT THE POSTER including the names of the authors and the title.
LEGEND
A =  THE MULTIFACETED BREAST CANCER: MOVING TOWARDS MOLECULAR PHENOTYPING
B = TUMOR STEM CELLS: RETHINKING BREAST CANCER
C =  INFLAMMATION & IMMUNITY
D =  CHEMOPREVENTION
E = IMAGING OF BREAST CANCER: CURRENT AND FUTURE METHODS
F =  FUTURE OF SURGERY AND CLASSIFICATION
G =  RADIATION THERAPY: WHEN, HOW, FOR WHOM
H = ENDOCRINE ADJUVANT THERAPIES: NEW STANDARDS AND NEW AVENUES
I = CHEMOTHERAPY, HER2/NEU AND OTHER TARGETED THERAPIES
L = SYSTEMIC THERAPIES: SPECIAL ISSUES
POSTER LIST
Cat  Title
A1 Estimation of individualized probabilities of developing breast cancer for Korean women
Chang Myung-Chul
A2 Polymorhism in CYP17, GSTM1 and progesterone recepttor genes and mammographic density
Chambo Danielle
A3 Prognostic and predictive biomarkers for breast cancer
O'Driscoll Lorraine
A4 Genetic characterization of three multiple breast carcinomas using compared genomic hybridization (CGH) technique
Carracedo A
A5 Phase I Clinical Study of the humanized monoclonal antiepidermal growth factor receptor (EGFR) antibody (Nimotuzumab) in combination with chemotherapy in patients with locally advanced breast cancer. Toxicity profile
Batista N
A6 RhoGDI-2 expression in human breast cancer tissues
Jung Eun-Jung
A7 Errors and imprecisions in collecting the family history data for identifying women at high risk of hereditary breast cancer
Baratelli Giorgio
A8 Comparing L-fucose and N-acetyl galactosaminyl oligosaccharide expression in intraductal breast carcinoma (using lectins)
Sepehri Zahra
A9 Estrogen receptor immunohistochemistry in breast cancer: differences between surgical specimens and core biopsy assessment
Frasson Antonio
A10 Primary diffuse large B-cell lymphoma of the breast, a differential diagnosis of inflammatory breast cancer
Joulaee A
A11 Current national pathology guidelines for the examination of sentinel lymph nodes in breast cancer are insufficient for the detection of micrometastases
Madsen Eva
A12 HER2/Neu expression in relation to clinico-pathoilogical features of breast cancer patients
Agostara Biagio
   
C1 MMTV involves into breast cancer progression during pregnancy and lactation
Parokonnaya AA
C2 Surgical closure of chest wall in noninflammatory locally advanced breast carcinoma with ulceration of the skin
Martella Stefano
   
D1 Epidemiologic study of 4,546 breast cancer patients in Thailand
Yaowanuch Kongdan
   
E1 Imaging cancer using genetically engeneered light-emitting bacteria
Park Min Ho
E2 Pathologic correlation of re-exised breast lesions after ultrasound guided vacuum-assisted device (mammotome) biopsy
Cho Young Up
E3 Importance of nuclear medicine 99mTc-MDP bone scan in the early detection of breast cancer bone metastasis
Peepre Karan
E4 Doppler eveluation by ecography in the axillary and lateral thoracic arteries as a complement in the diagnose of breast cancre - preliminary data
Pinotti Marianne
E5 Diabetic mastopathy: clinical, radiological and anatomopathologic findings
Pinotti Marianne
E6 Stromal fibrous mastopathy: clinical and radiological aspects
Pinotti Marianne
E7 The use of MRI in the monitoring of neoadjuvant chemotherapy in breast cancer
Pinotti Marianne
E8 Changes in the surgical management of patients wqith breast carcinoma based on preoperative magnetic resonance imaging
Millet Antonio
   
F1 The tennis racett operation
Hvid Helle
F2 A comparison between conventional conservative method and endoscope-assisted partial mastectomy with filling of dead space with polyglactin, with special focus on cosmesis and patien satisfaction
Takemoto Nobuyuki
F3 Prospective randomized study: high or low pressure aspiration system with redon type drain in patients undergoing radical axillary node dissection
Puig S
F4 Differences in surgical technique and seroma after radical axillary node dissection: prospective study
Salvans S
F5 Sentinel lymph node biopsy iniciate by an external Nuclear Medicine Department: impact before implementation
Segura A
F6 Sentinel lymph node biopsy in women with pT1 or microinvasive breast cancer
Fortunato Lucio
F7 The scoring system to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph node: comparison with other scoring systems and nomogram
Cho Jihyoung
F8 Effect of fibrin glue on lymphatic drainage afetre axillary lymphadenectomy in breast cancer. Prospective randomized study
Ko Eunyoung
F9 Occult lobular breast cancer metastatic to the uterus
Diaz Brito Jack Antonio
F10 Medullary carcinoma of the breast: case reports
Zitelli Ermanno
F11 Fibroadenoma with transition into adenoid carcinoma
Ristov Mitko
F12 Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes
Rubio Isabel T
F13 Series of oncoplastic surgery procedures in breast cancer patients
Bayram Yalcin
F14 A new method for nipple retraction
Bayram Yalcin
F15 One stage reconstruction with silicon implant after skin reducing subcutaneous mastectomy: a new technique
Bayram Yalcin
F16 Pure invasive micropapillary carcinoma of the breast: a histological type needing further evaluation?
Garcia-Fleury Isabel
F17 Clinical and terapeutic importance of sentinel node biopsy of the internal mammary chian in patients with breast cancer: a single-center study with long term follow-up
Carcoforo Paolo
F18 Primary breast cancer features can predict aditional lymph node involvement in patients with sentinel node micrometastases
Carcoforo Paolo
F19 Pregnancy associated breast cancer: factors influencing poor prognosis
Riaz Nazia
F20 TNM sytaging and classification (familial and non-familial) of breast cancer in Jordanian females
Manar Atoum
F21 Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: retrospective case-control study
Shin Hyuk Jai
F22 High resolution MR lymphoscintigraphy using USPIO in the evaluation of sentinel lymph nodes of breast cancer
Kimura Kose
F23 Carcinoma erysipeloides from breast cancer mimicking as radiodermatitis
Gokhan Sogutlu
F24 Experience of 56 cases of ductal carcinoma in situ (DCIS) at Jasmine Centre from October 1997 until January 2006
Siala Ali A
F25 Low morbidity and high patient satisfaction afetre treatment of breast cancer in Day-Surgery
Ferrari Alberta
F26 One day surgery in breast cancer patients: safe and feasible procedure
Giovanardi Filippo
F27 Stage migration in breast cancer: a trend towards better disease free survival for N0 patients since the introduction of the sentinel lymph node (SLN) procedure
Gobardhan Paul D
F28 Efficacy of methylene blue dye in localization of sentinel Lymph Node in breast cancer patients and a report of a new technique
Nour Ashraf
F29 Day-surgery: employable model for breast cancer patients
Ghilli Matteo
   
G1 Intraoperative radiotherapy with electrons (ELIOT) in breast surgery: new frontiers
Rodriguez Fernandez Julia
G2 Intraoperative radiotherapy in early breast cancer treatment
Frasson Antonio
   
H1 Estimating the risks and benefits of tamoxifen for breast cancer chemoprevention in Korea
Chang Myung-Chul
   
I1 Immunotheraeputic site in breast cancer: a new methodology for the autologous thermostable hemoderivative cancer vaccine
Garcia-Giralt Emilio
I2 Clinico-pathological features and outcomes of hormone-receptors positive (HR+) breast cancer (BC): analysis of 2686 patients (PTS) in a consecutive mono-institutional series with long follow-up
Ferro Antonella
I3 Determination of the correlation between Her-2 tumor factor and invasion of breast cancer to axillary lymph nodes in patients undergoing mastectomy in cancer Institute (2003-2006)
Shams Hosseini Narges Sadat
I4 Does preoperative chemotherapy influenece prognosis? (Evaluation of the 1998-2005 set)
Pecha V
I5 Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression
Sung-Won Kim
I6 Effect of Gemcitabine and cisplatin combination in taxane resistant metastatic breast cancer
Jun Suk Kim
I7 Metronomic chemotherapy with cyclophosphamide (CTX) and methotrexate (MTX) in metastatic breast cancer patients in progression
Lima M
I8 Persistance of bone marrow micrometastases in primary breast cancer patients: high dose versus standard chemotherapy versus endocrine regime. Results at 3.5 years
A. Zaidi
   
L1 Safety and pharmacokinetics evaluation of anti EGF receptor humanized monoclonal antibody nimotuzumab (HR3) in locally advanced breast cancer tumours in the neoadjuvant setting in combination with chemotherapy regimen. Phase I clinical trials. Preliminary
Ramos-Suzarte Mayra
L2 Rethinking undertreatment of elderly breast cancer patients
Seah Melanie